Bio Key International (BKYI) Common Equity (2016 - 2025)
Historic Common Equity for Bio Key International (BKYI) over the last 17 years, with Q3 2025 value amounting to $6.0 million.
- Bio Key International's Common Equity rose 444373.66% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 444373.66%. This contributed to the annual value of $3.8 million for FY2024, which is 25465.92% up from last year.
- Latest data reveals that Bio Key International reported Common Equity of $6.0 million as of Q3 2025, which was up 444373.66% from $6.9 million recorded in Q2 2025.
- Bio Key International's Common Equity's 5-year high stood at $19.6 million during Q1 2021, with a 5-year trough of -$1.1 million in Q2 2024.
- In the last 5 years, Bio Key International's Common Equity had a median value of $6.0 million in 2025 and averaged $7.7 million.
- As far as peak fluctuations go, Bio Key International's Common Equity crashed by 18483.65% in 2024, and later surged by 444373.66% in 2025.
- Quarter analysis of 5 years shows Bio Key International's Common Equity stood at $15.6 million in 2021, then plummeted by 66.05% to $5.3 million in 2022, then plummeted by 79.94% to $1.1 million in 2023, then skyrocketed by 254.66% to $3.8 million in 2024, then skyrocketed by 60.26% to $6.0 million in 2025.
- Its Common Equity was $6.0 million in Q3 2025, compared to $6.9 million in Q2 2025 and $7.5 million in Q1 2025.